RGEN

Repligen Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$166.52

Price (1 Year)

$189.68 $102.87

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %6.7 / %30
Non-compliant assets / Total market cap %1.6 / %30
Non-compliant revenue / Total income %3.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System.

Website

Analysis (Turkish): RGEN Hissesi Caiz mi, Helal mi? Repligen Corporation Katılım Analizi